Health Sciences Acquisitions Co. 2 (HSAQ) Competitors $2.71 +0.03 (+1.12%) As of 10/3/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsTrendsBuy This Stock HSAQ vs. NSPR, TMDIF, PETV, RVP, GBS, CTCX, BTCY, IVF, DYNT, and TTOOShould you be buying Health Sciences Acquisitions Co. 2 stock or one of its competitors? The main competitors of Health Sciences Acquisitions Co. 2 include InspireMD (NSPR), Titan Medical (TMDIF), PetVivo (PETV), Retractable Technologies (RVP), GBS (GBS), Carmell (CTCX), Biotricity (BTCY), INVO Fertility (IVF), Dynatronics (DYNT), and T2 Biosystems (TTOO). These companies are all part of the "surgical & medical instruments" industry. Health Sciences Acquisitions Co. 2 vs. Its Competitors InspireMD Titan Medical PetVivo Retractable Technologies GBS Carmell Biotricity INVO Fertility Dynatronics T2 Biosystems InspireMD (NYSE:NSPR) and Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, media sentiment, risk, institutional ownership, earnings and analyst recommendations. Does the media prefer NSPR or HSAQ? In the previous week, InspireMD's average media sentiment score of 0.00 equaled Health Sciences Acquisitions Co. 2'saverage media sentiment score. Company Overall Sentiment InspireMD Neutral Health Sciences Acquisitions Co. 2 Neutral Do analysts rate NSPR or HSAQ? InspireMD currently has a consensus target price of $4.50, suggesting a potential upside of 87.50%. Given InspireMD's stronger consensus rating and higher possible upside, analysts clearly believe InspireMD is more favorable than Health Sciences Acquisitions Co. 2.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score InspireMD 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Health Sciences Acquisitions Co. 2 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is NSPR or HSAQ more profitable? Health Sciences Acquisitions Co. 2 has a net margin of 0.00% compared to InspireMD's net margin of -413.96%. Health Sciences Acquisitions Co. 2's return on equity of 0.00% beat InspireMD's return on equity.Company Net Margins Return on Equity Return on Assets InspireMD-413.96% -69.42% -57.68% Health Sciences Acquisitions Co. 2 N/A N/A -2.38% Do institutionals and insiders have more ownership in NSPR or HSAQ? 44.8% of InspireMD shares are owned by institutional investors. Comparatively, 89.7% of Health Sciences Acquisitions Co. 2 shares are owned by institutional investors. 34.1% of InspireMD shares are owned by company insiders. Comparatively, 21.9% of Health Sciences Acquisitions Co. 2 shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has more volatility & risk, NSPR or HSAQ? InspireMD has a beta of 0.6, meaning that its share price is 40% less volatile than the S&P 500. Comparatively, Health Sciences Acquisitions Co. 2 has a beta of 0.09, meaning that its share price is 91% less volatile than the S&P 500. Which has better earnings and valuation, NSPR or HSAQ? Health Sciences Acquisitions Co. 2 has lower revenue, but higher earnings than InspireMD. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInspireMD$7.07M14.17-$19.92M-$0.83-2.89Health Sciences Acquisitions Co. 2N/AN/A-$380KN/AN/A SummaryInspireMD beats Health Sciences Acquisitions Co. 2 on 6 of the 11 factors compared between the two stocks. Get Health Sciences Acquisitions Co. 2 News Delivered to You Automatically Sign up to receive the latest news and ratings for HSAQ and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HSAQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSAQ vs. The Competition Export to ExcelMetricHealth Sciences Acquisitions Co. 2Surgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$30.39M$71.28M$6.11B$10.53BDividend YieldN/AN/A5.51%4.67%P/E RatioN/A10.9385.7226.89Price / SalesN/A41.25580.63183.63Price / CashN/A18.4126.3031.10Price / Book-4.3714.5013.236.68Net Income-$380K-$27.23M$3.30B$276.44M7 Day Performance10.16%2.28%4.85%3.12%1 Month Performance-1.45%0.77%8.50%10.19%1 Year Performance-45.58%65.95%87.78%40.24% Health Sciences Acquisitions Co. 2 Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSAQHealth Sciences Acquisitions Co. 2N/A$2.71+1.1%N/A-45.6%$30.39MN/A0.004NSPRInspireMD3.0384 of 5 stars$2.41-0.4%$4.50+86.7%-5.3%$100.55M$7.07M-3.2150TMDIFTitan MedicalN/A$0.44-1.4%N/A+1,226.1%$50.60M$17.63M-0.3550PETVPetVivoN/A$1.10+6.8%N/A+127.5%$32.17M$1.05M-2.4420News CoverageGap DownRVPRetractable Technologies1.7276 of 5 stars$0.84+2.7%N/A+19.8%$25.21M$38.16M-1.56240Gap DownGBSGBSN/A$1.14+1.8%N/A-26.4%$16.98MN/A-2.047CTCXCarmellN/A$0.74flatN/A+110.1%$15.47M$32.84K0.0014BTCYBiotricityN/A$0.53-1.9%N/A+62.0%$14.17M$12.06M-0.4940Gap DownIVFINVO Fertility0.1714 of 5 stars$0.76-7.2%N/A-96.8%$3.57M$6.53M-0.0110DYNTDynatronicsN/A$0.07-7.1%N/A-51.1%$857K$33.60M-0.08200Gap DownTTOOT2 BiosystemsN/A$0.01+0.8%N/A-99.4%$259K$7.68M0.00180Gap Up Related Companies and Tools Related Companies InspireMD Competitors Titan Medical Competitors PetVivo Competitors Retractable Technologies Competitors GBS Competitors Carmell Competitors Biotricity Competitors INVO Fertility Competitors Dynatronics Competitors T2 Biosystems Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HSAQ) was last updated on 10/7/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Health Sciences Acquisitions Co. 2 Please log in to your account or sign up in order to add this asset to your watchlist. Share Health Sciences Acquisitions Co. 2 With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
